Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin healthy volunteers challenged with Cryptosporidium parvum

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1324-1329

  Okhuysen, Pablo C ^c   Chappell, Cynthia L ^d   Crabb, Joseph ^d   Valdez, Luis M ^a   Douglass, Elizabeth T ^b   DuPont, Herbert L ^d  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b Milwaukee Medical Center SC   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE IMMUNOGLOBULIN; HYPERIMMUNE GLOBULIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ANTIPROTOZOAL ACTIVITY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLOSTRUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; MILK; NAUSEA; NORMAL HUMAN; OOCYST; ORAL DRUG ADMINISTRATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0031837722     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516374     Document Type: Article

References (30)

1. Goldstein S, Juraneck D, Ravenholt O, et al. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann Intern Med 1996;124:459-68.
2. MacKenzie W, Hoxie N, Proctor M, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994;331:161-7.
3. DuPont H, Chappell C, Sterling C, Okhuysen P, Rose J, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995;332:855-9.
4. + cells in response to Cryptosporidium parvum antigen. J Parasitol 1994;80:67-72.
5. + T lymphocytes and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 1993;61:3928-32.
6. McDonald V, Robinson H, Kelly J, Bancroft G. Cryptosporidium muris in adult mice: adoptive trasfer of immunity and protective roles of CD4 versus CD8 cells. Infect Immun 1994;62:2289-94.
7. Huang D, Lopez M, Wang J, Martines F, Watson R. Alterations of the mucosal immune system due to Cryptosporidium parvum infection in normal mice. Cellular Immunity 1996;173:176-82.
8. + intraepithelial lymphocytes. Infect Immun 1996;64:2556-62.
9. Rehg J. Effect of interferon-gamma in experimental Cryptosporidium parvum infection. J Infect Dis 1996;174:229-32.
10. Tilley M, McDonald V, Bancroft G. Resolution of cryptosporidial infection in mice correlates with parasite specific lymphocyte proliferation associated with both Th1 and Th2 cytokme secretion. Parasite Immunology 1995;17:459-64.
11. Lasser K, Lewin K, Ryning F. Cryptosporidial diarrhea in a patient with congenital hypogammaglobulinemia. Hum Pathol 1979;10:234-40.
12. Arrowood M, Mead J, Mahrt J, Sterling C. Effects of immune colostrum and orally administered antisporozoite monoclonal antibody on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect Immun 1989;57:2283-8.
13. Doyle P, Crabb J, Petersen C. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect Immun 1993;61: 4079-84.
14. Ungar B, Ward D, Fayer R, Quinn C. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient with hyperimmune bovine colostrum. Gastroenterology 1990;98: 486-9.
15. Fries L, Hillman K, Crabb J, et al. Clinical and microbiologic effects of bovine anti-Cryptosporidium immunoglobulin (BACI) on cryptosporidial diarrhea in AIDS. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, Florida). Washington, DC: American Society for Microbiology, 1994:198.
16. Arrowood M, Sterling C. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic percoll gradients. J Parasitol 1987;73:314-9.
17. DuPont H, Cooperstock M, Corrado M, Fekety R, Murray D. General guidelines for the evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Clin Infect Dis 1992;15(suppl 1):S228-35.
18. Ungar BLP, Soave R, Fayer R, Nash TE. Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised hosts. J Infect Dis 1986;153: 570-8.
19. Flanigan T. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses [review]. Am J Trop Med Hyg 1994;50:29-35.
20. Blagburn B, Soave R. Prophylaxis and chemotherapy: human and animal. In: Fayer R, ed. Cryptosporidium and cryptosporidiosis. Boca Raton, Florida: CRC Press, 1997:111-27.
21. Crabb J. Antibody based immunotherapy of cryptosporidiosis. Advances in Parasitology 1998;40:121-49.
22. Flanigan T, Marshall R, Redman D, Kaetzel C, Ungar B. In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow calostrum is highly inhibitory. J Protozool 1991;59:4610-3.
23. Fayer R, Guidry A, Blagbum B. Immunotherapeutic efficay of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infect Immun 1990;58:2962-5.
24. Tzipori S, Roberton D, Cooper D, White L. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet 1987;2:344.
25. Greenberg P, Cello P. Treatment of severe diarrhea casued by Cryplosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:348-54.
26. Saxon A, Weinstein W. Oral administration of bovine colostrum anti-cryptosporidia fails to alter the course of human cryptosporidiosis. J Parasitol 1987;73:413-5.
27. Butler J. Bovine immunoglobulins: an augmented review. Veterinary Immunology and Immunopathology 1983;4:43-152.
28. 15N-Labelled immunoglobulins from bovine colostrum are partially resistant to digestion in the human intestine. J Nutrition 1995;125:1238-44.
29. Riggs M, Cama V, Leary H, Sterling C. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun 1994;62:1927-39.
30. Hill B, Dawson A, Blewett D. Neutralisation of Cryptosporidium parvum sporozoites by immunoglobulin and nonimmunoglobulin components in serum. Res Vet Sci 1993;54:356-60.